Product Information
KARIVA 28 DAY TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1724 per EA under NDC 00555905058. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555905058
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075863FDA Approved
4/5/2002
TE Code
AB
On Market Since
4/8/2002
Price Statistics
The NADAC for KARIVA 28 DAY TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1724 per EA |
|---|---|
| All-time high | $1.1046 (Mar 12, 2014) |
| All-time low | $0.1319 (Apr 17, 2024) |
| 52-week high | $0.2029 |
| 52-week low | $0.1493 |
| Median price | $0.4661 |
| Average price | $0.5058 |
| Largest weekly change | +42.3% (Nov 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KARIVA 28 DAY TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KARIVA 28 DAY TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1724 per EA (NDC 00555905058), effective Sep 30, 2026.
How has the price of KARIVA 28 DAY TABLET changed over time?
Over the history we have for it, the NADAC for KARIVA 28 DAY TABLET has declined 84.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KARIVA 28 DAY TABLET?
Since Nov 28, 2013, the NADAC for KARIVA 28 DAY TABLET has ranged from a low of $0.1319 (Apr 17, 2024) to a high of $1.1046 (Mar 12, 2014), with a median of $0.4661 per EA.
Are there cheaper alternatives to KARIVA 28 DAY TABLET?
No other NADAC-published product currently shares the active ingredient and strength of KARIVA 28 DAY TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KARIVA 28 DAY TABLET?
KARIVA 28 DAY TABLET (NDC 00555905058) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.